510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1197-2014Class II

XiO RPT System The XiO RTP System is used to create treatment plans for any cancer patient for whom external...

Elekta Limited / initiated 2014-02-17 / Terminated / root cause: software

Elekta, Inc. began a recall of XiO RPT System The XiO RTP System is used to create treatment plans for any cancer patient for whom external beam radiation therapy or brachytherapy has been... on . FDA classified it as Class II and gives the reason as "Dose and Monitor Unit values are not computed correctly when Elekta Motorized Wedges are used with Dynamic Conformal arcs". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1197-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Elekta Limited
Product
XiO RPT System The XiO RTP System is used to create treatment plans for any cancer patient for whom external beam radiation therapy or brachytherapy has been prescribed. The system will calculate and display, both on screen and in hard-copy, either two or three dimensional radiation dose distributions within a patient for a given treatment.
Product code
MUJ System, Planning, Radiation Therapy Treatment
Reason for recall
Dose and Monitor Unit values are not computed correctly when Elekta Motorized Wedges are used with Dynamic Conformal arcs.
Root cause tag
software
FDA root cause
Software design
Action
Elekta, Inc. issued an Important Safety Notice (LINXi000019) issued February 14, 29, 2014. The Safety Notice identified the product, the problem, and the action to be taken by the customer. All affected customers of the issue globally by February 28, 2014. Provide a fix to the defect in an expeditious timeframe. It is mandatory for all customers to apply the fix. Version 5.00.01 will be released for the fix in March 2014. Follow up with the affected customers for confirmation receipt of the LIN, and confirmation of installation of patch for the fix by November 30, 2014. For questions regarding this recall call 770-670-2422.
Quantity in commerce
1776
Distribution
USA including AL, AK, AZ, CA, CO, CT, DE, DC, FL, GA, IL, IN, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NJ, NY, NC, ND, OH, OK, PA, RI, SC, TN, TX, VA, WA, WV, WI, WY, Puerto Rico and Internationally to Albania, Algeria, Argentina, Australia, Austria, Bahamas, Barbados, Bermuda, British Guiana, Boliva, Brazil, British West Indies, Burundi, Canada, Chile, China, Columbia, Costa Rica, Cuba, Curacao, Cyprus, Czechoslovakia, Dominica, Equator, Estonia, Egypt, Finland, France, Gambia, Germany, Great Britain, Georgia, Greece, Guatemala, Hong Kong, India, Indonesia, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Lativa, Lithunia, Madagascar, Malaysia, Malta, Mexico, Mongolia, Myanmar, Netherlands, New Zealand, Nigeria, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Russia, San Salvador, Saudia Arabia, Serbia, Singapore, Sir Lanka, South Korea, Spain, Sudan Slovenia, Suriname, Tajikistan, Thailand, Turkey, Turkmenistan, Taiwan, Ukraine, Uruguay, Venezuela, Viet Nam, Zambia.
Product codes and lots
Versions 4.1 and higher

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1197-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1197-2014Class IITerminatedVoluntary: Firm initiated